Verastem (VSTM) Other financing activities (2025 - 2026)
Verastem (VSTM) recorded quarterly Other financing activities of $700000.0 in Q1 2026, little changed quarter-over-quarter from $700000.0 in Q1 2025, and little changed on a YoY basis from $700000.0 in Q1 2025.
Verastem (VSTM) Other financing activities (2025 - 2026) Analysis & Trends
Verastem's Other financing activities history runs 2 years deep, the most recent figure standing at $700000.0 for Q1 2026.
- In Q1 2026, Other financing activities changed 0.0% year-over-year to $700000.0; the TTM figure through Mar 2026 stood at $1.4 million (changed N/A YoY), while the FY2025 annual figure was $800000.0, changed N/A from the prior year.
- Other financing activities was $700000.0 for Q1 2026 at Verastem, roughly flat from $700000.0 in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $700000.0 in Q1 2025 to a low of $700000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Verastem | 407.42 Mn | 225.74 Mn | 15.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 700,000.00 |
| Mar 31, 2026 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |
| Mar 31, 2025 | 700,000.00 |